Bacteriostatic preserved saline for pain-free periocular injections: review

Samantha Vicki Hunt, Raman Malhotra, Samantha Vicki Hunt, Raman Malhotra

Abstract

We review evidence regarding the use of 0.9% benzyl alcohol in 0.9% sodium chloride solution for periocular injections ('preserved saline') including botulinum toxin A injections and local anaesthesia. A literature search was undertaken using search terms 'bacteriostatic saline', 'benzyl-alcohol saline', 'benzyl alcohol sodium chloride' and 'preserved saline'. Bibliographies identified further sources. There have been 62 studies published on the subject of preserved-saline since 1928. Significantly lower injection-associated pain levels for periocular/facial botulinum toxin injections reconstituted with preserved-saline rather than preservative-free saline are reported by 5 studies. Significantly lower injection-associated pain with preserved-saline diluted lidocaine and epinephrine solution for eyelid anaesthesia compared with unmodified or buffered lidocaine with epinephrine, and adequate anaesthesia, was reported by one study. Thirty-one studies have explored preserved-saline for anaesthetic and seven for bacteriostatic properties, with very low infection rates after periocular botulinum toxin injections, and reduced rates of infection in indwelling catheters when preserved saline is used to flush. A meta-analysis concluded that lidocaine-containing solutions are more effective at reducing pain from insertion of intravenous catheters. Patient-perceived pain related to periorbital injections of local anaesthesia is reduced when the anaesthetic is diluted with benzyl alcohol-preserved saline compared with other dilution or buffering options. Pain is similarly reduced for periocular botulinum toxin injections reconstituted with preserved saline compared with unpreserved saline. Benzyl-alcohol preserved-saline is inexpensive but costlier than unpreserved-saline, with minimal reported complications, particularly with periocular administration, and offers the opportunity to improve the patient experience.

Conflict of interest statement

The authors declare no competing interests.

© 2022. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

References

    1. Shmunes E. Allergic dermatitis to Benzyl alcohol in an injectable solution. Arch Dermatol. 1984;120:1200–1. doi: 10.1001/archderm.1984.01650450082024.
    1. European Medicines Agency. Benzyl alcohol and benzoic acid group used as excipients. 2017:16. . Accessed 26 Aug 2021.
    1. Curry EJ, Warshaw EM. Benzyl alcohol allergy: importance of patch testing with personal products. Dermatitis. 2005;16:203–8.
    1. London Allergy and Immunology Centre. Patch Testing, Patch Tests & Chemical Allergy Tests [Internet]. London Allergy and Immunology Centre @ Harley Street Medical Centre UK (Private Allergy and Skin specialists). [cited 2021 Aug 26]. Available from: .
    1. Meinking TL, Villar ME, Vicaria M, Eyerdam DH, Paquet D, Mertz-Rivera K, et al. The clinical trials supporting Benzyl alcohol lotion 5% (UlesfiaTM): a safe and effective topical treatment for head lice (Pediculosis Humanus Capitis) Pediatr Dermatol. 2010;27:19–24. doi: 10.1111/j.1525-1470.2009.01059.x.
    1. Nair B. Final report on the safety assessment of Benzyl alcohol, Benzoic acid, and sodium Benzoate. Int J Toxicol. 2001;20:23–50. doi: 10.1080/10915810152630729.
    1. Wiernikowski JT, Elder-Thornley D, Dawson S, Rothney M, Smith S. Bacterial colonization of tunneled right atrial catheters in pediatric oncology: a comparison of sterile saline and bacteriostatic saline flush solutions. Am J Pediatr Hematol Oncol. 1991;13:137–40. doi: 10.1097/00043426-199122000-00004.
    1. Macht DI, Leach HP. Concerning the antipyretic properties of Benzyl Benzoate. J Pharmacol Exp Ther. 1929;35:281–96.
    1. Fein JA, Boardman CR, Stevenson S, Selbst SM. Saline benzyl alcohol intradermal anesthesia intravenous line Place Child: Pediatr Emerg Care. 1998;14:119–22.
    1. Minogue SC, Sun DA. Bacteriostatic saline containing benzyl alcohol decreases the pain associated with the injection of propofol. Anesth Analg. 2005;100:683–6. doi: 10.1213/01.ANE.0000148617.98716.EB.
    1. McCarthy TJ, Ferreira J-H. Attempted measurement of the activity of selected preservative combinations. J Clin Pharm Ther. 1990;15:123–9. doi: 10.1111/j.1365-2710.1990.tb00366.x.
    1. Drugs@FDA: FDA-Approved Drugs [Internet]. [cited 2021 Sep 5]. Available from: .
    1. Patterson P, Hussa AA, Fedele KA, Vegh GL, Hackman CM. Comparison of 4 analgesic agents for venipuncture. AANA J. 2000;68:43–51.
    1. Ganter-Ritz V, Speroni KG, Atherton M. A randomized double-blind study comparing intradermal anesthetic tolerability, efficacy, and cost-effectiveness of lidocaine, buffered lidocaine, and bacteriostatic normal saline for peripheral intravenous insertion. J Infus Nurs. 2012;35:93–9. doi: 10.1097/NAN.0b013e31824241cc.
    1. Oman KS, Fink R, Kleiner C, Makic MBF, Wenger B, Hoffecker L, et al. Intradermal lidocaine or bacteriostatic normal saline to decrease pain before intravenous catheter insertion: a meta-analysis. J Perianesth Nurs. 2014;29:367–76. doi: 10.1016/j.jopan.2013.12.008.
    1. Deguzman ZC, O’Mara SK, Sulo S, Haines T, Blackburn L, Corazza J. Bacteriostatic normal saline compared with buffered 1% lidocaine when injected intradermally as a local anesthetic to reduce pain during intravenous catheter insertion. J Perianesth Nurs. 2012;27:399–407. doi: 10.1016/j.jopan.2012.08.005.
    1. McNelis KA. Intradermal bacteriostatic 0.9% sodium chloride containing the preservative benzyl alcohol compared with intradermal lidocaine hydrochloride 1% for attenuation of intravenous cannulation pain. AANA J. 1998;66:583–5.
    1. Frenken LAM, van Lier HJJ, Koene RAP. Analysis of the efficacy of measures to reduce pain after subcutaneous administration of epoetin alfa. Nephrol Dial Transplant [Internet]. 1994 [cited 2021 Sep 30]; Available from: .
    1. Kruse RC, Kindle BJ, Wisniewski S, Presley J, Smith J, Sellon JL. Local anesthesia prior to ultrasound-guided hip joint injections: a double-blind randomized controlled trial of bacteriostatic saline versus buffered lidocaine. PMR. 2021;13:811–8. doi: 10.1002/pmrj.12489.
    1. Miller L, Jensen MP, Stenchever MA. A double-blind randomized comparison of lidocaine and saline for cervical anesthesia. Obstet Gynecol. 1996;87:600–4. doi: 10.1016/0029-7844(95)00463-7.
    1. Gostimir M, Hussain A. A systematic review and meta-analysis of methods for reducing local anesthetic injection pain among patients undergoing periocular surgery. Ophthal Plast Reconstr Surg. 2019;35:113–25. doi: 10.1097/IOP.0000000000001209.
    1. Han J, Nah SK, Lee SY, Kim CY, Yoon JS, Jang SY. A prospective, comparative study of the pain of local anesthesia using 2% lidocaine, 2% lidocaine with epinephrine, and 2% lidocaine with epinephrine–bupivicaine mixture for eyelid surgery. Ophthal Plast Reconstr Surg. 2017;33:132–5. doi: 10.1097/IOP.0000000000000675.
    1. Yuen VH, Dolman PJ. Comparison of three modified lidocaine solutions for use in eyelid anesthesia. Ophthal Plast Reconstr Surg. 1999;15:143–7. doi: 10.1097/00002341-199903000-00017.
    1. Dolman PJ, Yuen VH. Re: ‘a systematic review and meta-analysis of methods for reducing local anesthetic injection pain among patients undergoing periocular surgery’. Ophthal Plast Reconstr Surg. 2019;35:412–3. doi: 10.1097/IOP.0000000000001417.
    1. Alam M, Dover JS, Arndt KA. Pain associated with injection of botulinum a exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trial. Arch Dermatol. 2002;138:510–4. doi: 10.1001/archderm.138.4.510.
    1. Kwiat DM, Bersani TA, Bersani A. Increased patient comfort utilizing botulinum toxin type a reconstituted with preserved versus nonpreserved saline. Ophthal Plast Reconstr Surg. 2004;20:186–9. doi: 10.1097/01.IOP.0000129012.09632.49.
    1. van Laborde S, Dover JS, Moore M, Stewart B, Arndt KA, Alam M. Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: a double-blind, randomized controlled trial. J Am Acad Dermatol. 2003;48:875–7. doi: 10.1067/mjd.2003.487.
    1. Allen SB, Goldenberg NA. Pain difference associated with injection of abobotulinumtoxina reconstituted with preserved saline and preservative-free saline: a prospective, randomized, side-by-side, double-blind study. Dermatol Surg. 2012;38:867–70. doi: 10.1111/j.1524-4725.2011.02284.x.
    1. Wightman MA, Vaughan RW. Comparison of compounds used for intradermal anesthesia. Anesthesiology. 1976;45:687–9. doi: 10.1097/00000542-197612000-00024.
    1. Wilson L, Martin S. Benzyl alcohol as an alternative local anesthetic. Ann Emerg Med. 1999;33:495–9. doi: 10.1016/S0196-0644(99)70335-5.
    1. Jolliffe VML, Sinclair RD. Excision biopsy in a patient with suspected local anaesthetic allergy: use of 0.9% saline with benzyl alcohol as local anaesthesia: Use of 0.9% saline with benzyl alcohol as local anaesthesia in an allergic patient. Clin Exp Dermatol. 2012;37:862–4. doi: 10.1111/j.1365-2230.2012.04338.x.
    1. Lugo-Janer G, Padial M, Sánchez JL. Less painful alternatives for local anesthesia. J Dermatol Surg Oncol. 1993;19:237–40. doi: 10.1111/j.1524-4725.1993.tb00342.x.
    1. McKay W, Morris R, Mushlin P. Sodium bicarbonate attenuates pain on skin infiltration with lidocaine, with or without epinephrine. Anesth Analg. 1987;66:572–4. doi: 10.1097/00000542-198704000-00027.
    1. Burgher SW, McGuirk TD. Subcutaneous buffered lidocaine for intravenous cannulation: is there a role in emergency medicine? Acad Emerg Med. 1998;5:1057–63. doi: 10.1111/j.1553-2712.1998.tb02662.x.
    1. Peter W, Lewis M, Macres M. Pain comparison after subcutaneous administration of single-dose formulation versus multidose formulation of epogen in hemodialysis patients. Am J Kidney Dis. 1998;32:470–4. doi: 10.1053/ajkd.1998.v32.pm9740164.
    1. Zakria D, Patrinely JR, Dewan AK, Albers SE, Wheless LE, Simmons AN, et al. Intralesional corticosteroid injections are less painful without local anesthetic: a double-blind, randomized controlled trial. J Dermatol Treat. 2021:7;1–4.
    1. Storey TF, Gilbride G, Clifford K. Postprocedural pain in shoulder arthrography: differences between using preservative-free normal saline and normal saline with benzyl alcohol as an intraarticular contrast diluent. Am J Roentgenol. 2014;203:1059–62. doi: 10.2214/AJR.13.11190.
    1. Glantz JC, Shomento S. Comparison of paracervical block techniques during first trimester pregnancy termination. Int J Gynecol Obstet. 2001;72:171–8. doi: 10.1016/S0020-7292(00)00292-7.
    1. Carruthers A, Carruthers J. History of the cosmetic use of botulinum a exotoxin. Dermatol Surg. 1998;24:1168–71.
    1. Clark RP, Berris CE. Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg. 2005;115:573–4. doi: 10.1097/01.PRS.0000150149.74749.55.
    1. Fortune Business Insights. Botulinum Toxin Market Size & Share | Global Report [2020–2027] [Internet]. The global botulinum toxin market size was $4.83 billion in 2019 & is projected to reach $7.71 billion by 2027, exhibiting a CAGR of 7.5% in forecast period… 2020 [cited 2021 Aug 29]. Available from: .
    1. Solutions TKISG American Academy of Facial Plastic and Reconstructive Surgery [Internet]. American Academy of Facial Plastic and Reconstructive Surgery. [cited 2021 Aug 29]. Available from: .
    1. Rice SM, Graber E, Kourosh AS. A pandemic of dysmorphia: “Zooming” into the perception of our appearance. Facial Plast Surg Aesthetic Med. 2020;22:401–2. doi: 10.1089/fpsam.2020.0454.
    1. Zidan A, Hussaini S, Gibson S, Brooks G, Mejico L. Onabotulinumtoxin Type A reconstitution with preserved versus preservative‐free saline in chronic migraine (B‐RECON). A randomised, double‐blind trial. Int J Clin Pract [Internet]. 2020 Sep [cited 2021 Sep 30];74. Available from: .
    1. Sarifakioglu N, Sarifakioglu E. Evaluating effects of preservative-containing saline solution on pain perception during botulinum toxin Type-A injections at different locations: a prospective, single-blinded, randomized controlled trial. Aesthetic Plast Surg. 2005;29:113–5. doi: 10.1007/s00266-004-0062-0.
    1. Huang L, Costin BR, Sakolsatayadorn N, Perry JD. Safety of onabotulinum toxin a injection to the central upper eyelid and eyebrow regions. Ophthal Plast Reconstr Surg. 2014;30:377–80. doi: 10.1097/IOP.0000000000000109.
    1. Rein MF, Mandell GL. Bacterial killing by bacteriostatic saline solutions — potential for diagnostic error. N. Engl J Med. 1973;289:794–5. doi: 10.1056/NEJM197310112891508.
    1. Shenep LE, Shenep MA, Cheatham W, Hoffman JM, Hale A, Williams BF, et al. Efficacy of intravascular catheter lock solutions containing preservatives in the prevention of microbial colonization. J Hosp Infect. 2011;79:317–22. doi: 10.1016/j.jhin.2011.07.010.
    1. Pham T, Perry JD. Botulinum toxin type A injection without isopropyl alcohol antisepsis. Ophthal Plast Reconstr Surg. 2009;25:178–9. doi: 10.1097/IOP.0b013e3181a145e5.
    1. American Academy of Paediatrics Committee on Fetus and Newborn. Benzyl Alcohol: Toxic Agent in Neonatal Units. Pediatrics. 1983;72:356–8.
    1. Saito J, Nadatani N, Setoguchi M, Nakao M, Kimura H, Sameshima M, et al. Potentially harmful excipients in neonatal medications: a multicenter nationwide observational study in Japan. J Pharm Health Care Sci. 2021;7:23. doi: 10.1186/s40780-021-00208-9.
    1. Hetherington NJ, Dooley MJ. Potential for patient harm from intrathecal administration of preserved solutions. Med J Aust. 2000;173:141–3. doi: 10.5694/j.1326-5377.2000.tb125570.x.
    1. Messinger YH, Maxa KL, Hennen EM, Gossai NP, Hoff DS. Intrathecal methotrexate containing the preservative benzyl alcohol erroneously administered in pediatric leukemia patients: clinical course and preventive process. J Pediatr Pharm Ther JPPT. 2020;25:328–31.
    1. Craig DB, Habib GG. Flaccid paraparesis following obstetrical epidural anesthesia: possible role of benzyl alcohol. Anesth Analg. 1977;56:219–21.
    1. Hahn AF, Feasby TE, Gilbert JJ. Paraparesis following intrathecal chemotherapy. Neurology. 1983;33:1032–8. doi: 10.1212/WNL.33.8.1032.
    1. Reynolds RD. Nebulizer bronchitis induced by bacteriostatic saline. JAMA J Am Med Assoc. 1990;264:35. doi: 10.1001/jama.1990.03450010039017.
    1. Reynolds RD, Smith RM. Nebulized bacteriostatic saline as a cause of bronchitis. J Fam Pr. 1995;40:35–40.
    1. Fisher AA. Allergic paraben and benzyl alcohol hypersensitivity relationship of the “delayed” and “immediate” varieties. Contact Dermat. 1975;1:281–4. doi: 10.1111/j.1600-0536.1975.tb05436.x.
    1. Guin JD, Goodman J. Contact urticaria from benzyl alcohol presenting as intolerance to saline soaks: SHORT COMMUNICATION. Contact Dermat. 2001;45:182–3. doi: 10.1034/j.1600-0536.2001.045003182.x.
    1. Amado A, Jacob SE. Letter: benzyl alcohol preserved saline used to dilute injectables poses a risk of contact dermatitis in fragrance-sensitive patients. Dermatol Surg. 2007;33:1396–7.
    1. Mountainside Medical Equipment. Bacteriostatic Sodium Chloride 0.9% for Injection 20ml - Single Vial [Internet]. Mountainside Medical Equipment. [cited 2021 Sep 16]. Available from: .
    1. TOR-BAC Bacteriostatic Sodium Chloride Ampoules Solution [Internet]. Fox Pharma. [cited 2021 Sep 30]. Available from: .
    1. Klein AW. Dilution and storage of botulinum toxin. Dermatol Surg. 1998;24:1179–80.
    1. Allergan, Inc. Highlights of Prescribing Information: BOTOX [Internet]. Allergan, Inc; 2021 [cited 2021 Sep 5]. Available from: .
    1. Alam M, Yoo SS, Wrone DA, White LE, Kim JYS. Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulation. J Am Acad Dermatol. 2006;55:272–5. doi: 10.1016/j.jaad.2006.01.019.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe